Addressing disparities in cancer clinical trials: a roadmap to more equitable accrual

被引:0
|
作者
Hoin, Jon A. [1 ]
Carthon, Bradley C. [2 ]
Brown, Shantoria J. [3 ]
Durham, Lynn M. [3 ]
Garrot, L. Crain [4 ]
Ghamande, Sharad A. [5 ]
Pippas, Andrew W. [6 ]
Rivers, Brian M. [7 ]
Snyder, Cindy T. [3 ]
Gabram-Mendola, Sheryl Gordon Ann [3 ,8 ]
机构
[1] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA USA
[2] Emory Univ, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA USA
[3] Georgia Ctr Oncol Res & Educ, Atlanta, GA 30309 USA
[4] Georgia Canc Specialists, Atlanta, GA USA
[5] Augusta Univ Hlth, Dept Obstet & Gynecol, Augusta, GA USA
[6] Piedmont HealthCare, Columbus, GA USA
[7] Morehouse Sch Med, Canc Hlth Equ Inst, Atlanta, GA USA
[8] Emory Univ, Atlanta, GA 30322 USA
来源
关键词
cancer care access; clinical trials; disparities; clinical trial accrual; navigation; NAVIGATION; BARRIERS; IMPACT; BREAST;
D O I
10.3389/frhs.2024.1254294
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
The Georgia Center for Oncology Research and Education (Georgia CORE) and the Georgia Society of Clinical Oncology (GASCO) held a one-day summit exploring opportunities and evidence-based interventions to address disparities in cancer clinical trials. The purpose of the summit was to identify clear and concise recommendations aimed at decreasing clinical trial accrual disparities in Georgia for rural and minority populations. The summit included expert presentations, panel discussions with leaders from provider organizations throughout Georgia, and breakout sessions to allow participants to critically discuss the information presented. Over 120 participants attended the summit. Recognizing the need for evidence-based interventions to improve clinical trial accrual among rural Georgians and persons of color, summit participants identified four key areas of focus that included: improving clinical trial design, providing navigation for all, enhancing public education and awareness of cancer clinical trials, and identifying potential policy and other opportunities. A comprehensive list of takeaways and action plans was developed in the four key areas of focus with the expectation that implementation of the strategies that emerged from the summit will enhance cancer clinical trial accrual for all Georgians.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Strengthening accrual to cancer clinical trials
    Trimble, Edward L.
    Denicoff, Andrea M.
    Abrams, Jeffrey S.
    [J]. GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : 291 - 292
  • [2] Disparities in older adult accrual to cancer trials: Analysis from the alliance for clinical trials in oncology (A151736)
    VanderWalde, Noam A.
    Dockter, Travis
    Wakefield, Daniel, V
    Satele, Daniel
    Sloan, Jeff
    Jagsi, Reshma
    Lichtman, Stuart M.
    Freedman, Rachel A.
    Lafky, Jacqueline M.
    Muss, Hyman
    Cohen, Harvey Jay
    Le-Rademacher, Jennifer
    Jatoi, Aminah
    [J]. JOURNAL OF GERIATRIC ONCOLOGY, 2022, 13 (01) : 20 - 26
  • [3] Addressing the Barriers to Clinical Trials Accrual in Community Cancer Centres Using a National Clinical Trials Navigator:A Cross-Sectional Analysis
    Hamm, Caroline
    Cavallo-Medved, Dora
    Moudgil, Devinder
    McGrath, Lee
    Huang, John
    Li, Yueyang
    Stratton, Tyler W.
    Robinson, Tyler
    Naccarato, Krista
    Sundquist, Stephen
    Dancey, Janet
    [J]. CANCER CONTROL, 2022, 29
  • [4] Addressing the Barriers to Clinical Trials Accrual in Community Cancer Centres Using a National Clinical Trials Navigator:A Cross-Sectional Analysis
    Hamm, Caroline
    Cavallo-Medved, Dora
    Moudgil, Devinder
    McGrath, Lee
    Huang, John
    Li, Yueyang
    Stratton, Tyler W.
    Robinson, Tyler
    Naccarato, Krista
    Sundquist, Stephen
    Dancey, Janet
    [J]. CANCER CONTROL, 2022, 29
  • [5] Conceptual Model for Accrual to Cancer Clinical Trials
    Lee, Simon J. Craddock
    Murphy, Caitlin C.
    Geiger, Ann M.
    Gerber, David E.
    Cox, John V.
    Nair, Rasmi
    Skinner, Celette Sugg
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (23) : 1993 - +
  • [6] Accrual issues in genitourinary cancer clinical trials
    Lara, Primo N., Jr.
    White, Ralph de Vere
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2006, 24 (05) : 379 - 383
  • [7] Addressing the Barriers to Clinical Trials Accrual in Community Cancer Centres Using a National Clinical Trials Navigator:A Cross-Sectional Analysis
    Hamm, Caroline
    Cavallo-Medved, Dora
    Moudgil, Devinder
    McGrath, Lee
    Huang, John
    Li, Yueyang
    Stratton, Tyler W.
    Robinson, Tyler
    Naccarato, Krista
    Sundquist, Stephen
    Dancey, Janet
    [J]. CANCER CONTROL, 2022, 29
  • [8] Addressing both community and institutional barriers increases accrual of minority patients in breast cancer clinical trials
    Trant, Amelia A.
    Walz, Lucas
    Allen, Whitney
    Verma, Hannah
    Le, Mindy
    DeJesus, Jose
    Hatzis, Christos
    Silber, Andrea
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2020, 29 (06)
  • [9] Cancer clinical trials accrual: Missed opportunities to address disparities and missed opportunities to improve outcomes for all
    Newman, Lisa A.
    Roff, Nathalie Kim
    Weinberg, Armin D.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2008, 15 (07) : 1818 - 1819
  • [10] Cancer Clinical Trials Accrual: Missed Opportunities to Address Disparities and Missed Opportunities to Improve Outcomes for All
    Lisa A. Newman
    Nathalie Kim Roff
    Armin D. Weinberg
    [J]. Annals of Surgical Oncology, 2008, 15 : 1818 - 1819